DAS181

· Ansun Biopharma, Inc.

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for DAS181, covering 2017-07-19 to 2020-08-11. Get the full timeline:

Most recent: Clinical Trial Update: DAS181 for STOP COVID-19 [Phase 2, Phase 3]